Boston, MA · Founded 2014 · Privately Held (backing)
Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. NFlection Therapeutics is based in Boston, MA and was founded in 2014. It was valued at $156 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $65.5 million across 3 recorded rounds; the latest was a $4 million seed round in Jul 2023.
PMV mark · valuation
$156.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$65.5M
Last round
Seed Round
Jul 2023
Cap table — not yet on record
NFlection Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NFlection Therapeutics with a free account
·Watch NFlection Therapeutics: the Monday email on marks, rounds and moves
Where does NFlection Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NFlection Therapeutics's 3 recorded funding rounds.
